Nasdaq smmt.

Dec 6, 2022 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ... OXFORD, United Kingdom, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...WebSummit Therapeutics Inc. (NASDAQ:NASDAQ:SMMT) Q4 2022 Results Conference Call March 9, 2023 9:00 AM ETCompany ParticipantsDave Gancarz - SVP, Corporate...Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.Web

View the latest SMMT insider trading activity at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Summit Therapeutics (NASDAQ:SMMT) Insider Buying and Selling Activity. Current Insider Ownership Percentage 83.70%. Number Of Insiders Buying (Last 12 Months) 4. Amount Of Insider …WebShares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report) were down 3.9% on Friday .The company traded as low as $1.94 and last traded at …

View live Summit Therapeutics Inc. chart to track its stock's price action. Find market predictions, SMMT financials and market news.

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Nov 27, 2023 · 78% of the company is held by a single shareholder (Robert Duggan) Insiders have been buying lately. If you want to know who really controls Summit Therapeutics Inc. ( NASDAQ:SMMT ), then you'll ... Summit Therapeutics Inc. Common Stock (SMMT) Nasdaq Listed. DATA AS OF Nov 26, 2021. 0. Add to Watchlist. Add to Portfolio. SMMT SMMT HISTORICAL DATA.Cambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has approved a rights offering available to all holders of record of ...Cambridge, MA, May 17, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the first quarter ended March 31, 2021.

Summit Therapeutics Inc. (NASDAQ:SMMT) has the sixth position on our list of the ten best penny stocks to buy in September. It is a Cambridge, Massachusetts-based clinical-stage drug discovery and ...Web

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Web

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebNov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. Oxford, UK, and Cambridge, MA, US, 27 March 2019 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today reports its financial results for the ...3 de fev. de 2023 ... Summit Therapeutics (NASDAQ:SMMT) shares are plummeting over 40% on Friday morning. Gaucho Group Holdings (NASDAQ:VINO) stock is diving more ...The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebOXFORD, United Kingdom, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces further positive findings from PhaseOut DMD, a Phase 2 open-label, multi-centre ...

Find the latest Insider Activity data for Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com. Summit Therapeutics Inc. Common Stock (SMMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Summit Therapeutics (NASDAQ: SMMT ) announced during its Third Quarter 2023 Earnings and Update Call that it has started enrolling for the second Phase III clinical trial for ivonescimab, a potential treatment for non-small cell lung cancer. The company also introduced its new Chief Operating Officer, Manmeet Soni, who has made a $5 million …WebSummit Therapeutics Inc. (NASDAQ:SMMT) Short Interest Up 2,045.6% in December marketbeat.com - December 28 at 1:08 PM: Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week finance.yahoo.com - December 9 at 2:06 PM: marketbeat.com - December 9 at 10:28 AMCambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has approved a rights offering available to all holders of record of ...há 6 dias ... Get the latest Summit Therapeutics Inc. price, NASDAQ-SMMT market cap, charts, market status & all analytical data.Oxford, UK, and Cambridge, MA, US, June 8, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that Mr. Michael Donaldson has been appointed as Chief Financial Officer, effective ...

Nov 7, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Short Interest Up 2,045.6% in December marketbeat.com - December 28 at 1:08 PM: Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week finance.yahoo.com - December 9 at 2:06 PM: marketbeat.com - December 9 at 10:28 AM

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...By way of example, Summit Therapeutics (NASDAQ:SMMT) has seen its share price rise 106% over the last year, delighting many shareholders. Having said that, unprofitable companies are risky because ...Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.OXFORD, United Kingdom, April 28, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...Cambridge, MA, November 23, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Mahkam “Maky” Zanganeh, DDS, MBA, has been appointed as Chief Operating Officer, effective ...Summit Therapeutics Inc. (NASDAQ:SMMT) insiders placed bullish bets worth US$62m in the last 12 months. (Simply Wall St.) Mar-17-22 04:14PM. Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021. (GlobeNewswire) +7.93%.SMMT Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. / Summit Therapeutics Inc NASDAQ: SMMT is a biopharmaceutical company focused on discovering, developing, and commercializing antibiotics for serious infectious ...

Dec 4, 2023 · TG Therapeutics Inc (NASDAQ:TGTX)’s Major holders. Insiders own 8.59% of the company shares, while shares held by institutions stand at 64.76% with a share float percentage of 70.85%. Investors are also buoyed by the number of investors in a company, with TG Therapeutics Inc having a total of 282 institutions that hold shares in the company.

Oxford, UK, and Cambridge, MA, US, 25 February 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, published preclinical data on SMT-571, a ...

LIESTAL, Switzerland, OXFORD, England and CAMBRIDGE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Santhera Pharmaceuticals (SIX:SANN), Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), Catabasis ...Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BABA. 73.60. -1.71%. 19.59M. New. View today's Summit Therapeutics PLC stock price and latest SMMT news and analysis. Create real-time notifications to follow any changes in …Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily …Dec 4, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT)’s Major holders. Insiders own 29.61% of the company shares, while shares held by institutions stand at 3.27% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with Summit Therapeutics Inc having a total of 119 institutions that hold shares in the ... Research Summit Therapeutics' (Nasdaq:SMMT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...Principal Financial Group Inc. purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 13,679 shares of the company’s stock, valued at approximately $34,000. A number of other […]

OXFORD, United Kingdom, April 28, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...OXFORD, United Kingdom, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) the drug discovery and development company advancing therapies for Duchenne muscular ...Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. All participants will be able to listen only until the question-and-answer portion of this call. We do not expect any …Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on ...Instagram:https://instagram. best place to buy optionsshort term disability insurance comparisonbest growth fundsbest insurance for jewelry Based on analysts offering 12 month price targets for SMMT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . boil futureshow to invest in wells fargo stock Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ...Oxford, UK, and Cambridge, MA, US, 6 February 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it achieved the first milestone under its license and collaboration ... ark fintech innovation etf As part of this collaboration deal, Summit Therapeutics paid $500 million upfront (financed via a rights offering) and could be on the hook for another $4.5 billion in future milestone payouts ($1 ...Dec 4, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT)’s Major holders. Insiders own 29.61% of the company shares, while shares held by institutions stand at 3.27% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with Summit Therapeutics Inc having a total of 119 institutions that hold shares in the ...